Open Access

The phenomenology and natural history of idiopathic lower cranial dystonia

  • Pichet Termsarasab1Email author,
  • Donald R Tanenbaum1 and
  • Steven J Frucht1
Journal of Clinical Movement Disorders20141:3

https://doi.org/10.1186/2054-7072-1-3

Received: 28 March 2014

Accepted: 7 May 2014

Published: 29 October 2014

Abstract

Background

Many patients with lower cranial dystonia (LCrD) are misdiagnosed, and recognition of this condition by general practitioners and dental health professionals is limited.

Methods

We define the phenomenology and natural history of idiopathic LCrD, presenting in 41 patients with the disorder, the largest series of these patients reported to date.

Results

Phenomenology of dystonia included lower cranial and pharyngeal involvement, jaw opening and jaw closing dystonia, and tongue dystonia. Of 25 newly described patients, 72% (18) were female, average age at onset was 56 years, and delay before correct diagnosis was 3.8 years (0-25 years, median 2 years). Eleven patients (44%) reported a precipitating event, the most common of which was recent dental work. Geste antagonistes were found in 18 patients (72%). Response to treatment was mixed, indicating an unmet therapeutic need.

Conclusions

Idiopathic LCrD is often missed and institution of effective therapy is often delayed. The clinical features and natural history of LCrD are similar to other forms of focal dystonia.

Keywords

Lower cranial dystoniaOromandibular dystoniaGeste antagoniste

Background

Lower cranial dystonia (LCrD), focal dystonia of the muscles of the lower face, jaw, tongue and pharynx, may be seen in a variety of scenarios including tardive dystonia, DYT6 and DYT12, and in neurodegenerative disorders such as Wilson’s disease and neurodegeneration with brain iron accumulation (NBIA). In contrast, isolated LCrD occurring without other abnormalities is distinctly rare. Many patients with LCrD are misdiagnosed, and recognition of this condition by general practitioners and dental health professionals is limited, delaying appropriate diagnosis and treatment. Two hundred and twenty eight patients with lower cranial dystonia have been reported in at least 8 prior case series/reports [18], however significant limitations in these reports include; 1) mixing of patients with tardive or other secondary forms of LCrD; 2) inclusion of patients with dystonia in other body regions such as the upper face or neck; and, 3) lack of detailed phenomenologic descriptions. We present 41 patients with idiopathic LCrD (25 newly reported), the largest report to date of idiopathic LCrD, in order to increase awareness and facilitate diagnosis and treatment of this unusual condition.

Methods

Twenty-five patients with idiopathic LCrD were evaluated by the senior movement disorders neurologist (SJF) over a period of eight years. Many patients were referred by dentists or oral surgeons (DT). Patients with secondary dystonia or with exposure to dopamine receptor blocking agents were excluded. Clinical history, examination, and video review were performed (PT, SJF). Age at onset, duration of symptoms, precipitating factors, clinical phenomenology, the presence or absence of geste maneuvers, task-specificity, aggravating and relieving factors, and associated symptoms and treatment response are summarized in Table 1.
Table 1

Summary of clinical features including phenomenology of 41 patients with idiopathic LCrD

Number

Gender

Age at onset

Duration

Areas affected

Primary movement

Task specificity

Precipitating event

Sensory trick

Associated symptoms

Treatment

Oral device; response

1

F

65

2

Jaw

Jaw opening

Speech, eating, chewing

Dental work

None

None

LD (no), BoNT (no, dysphagia), THP (no), CLZ (no), baclofen (unknown)

N

2

F

71

1

Jaw

L jaw deviation

Eating, chewing, speech

Mandibular fx after a fall

None

None

THP (yes, 2–4 mg/d)

N

3

F

59

2

Jaw

Jaw opening and protrusion

Speech -- > eating, chewing

Maxillary bridge replacement

Plastic between teeth

Pain/clicking in TMJ

THP (no)

N

4

F

53

0

Jaw

Jaw opening

Speech -- > eating

None

Plastic/tongue depressor between teeth > holding jaw

R ear clicking, lower jaw pain

THP (no), BoNT (no), Baclofen (no), TBZ (no, depression), CLZ (no, sedation), DZP (unknown)

N

5

F

46

2

Jaw

Jaw opening

Speech -- > eating

None

Plastic between teeth, holding jaw

None

CLZ (no), THP (unknown), BoNT (yes, mild)

Y; initial response

6

M

61

1

Pharynx, larynx

Pharyngeal/laryngeal dystonia

Speech (worse with ke, ge sounds)

R sinus lift and dental implant

Plastic/tongue depressor between teeth

None

THP (yes, 6–15 mg/d)

N

7

F

73

1

Jaw

R jaw deviation

At rest

None

Plastic between teeth on the L

None

THP (no), CLZ (1 mg/d, unknown)

N

8

F

70

1

Jaw

Jaw opening

Speech

Cheering a football game

Tongue depressor between lip/teeth; holding jaw

None

CLZ (no), LD (no), THP (no), Baclofen (no), BoNT (no)

N

9

F

51

2

Jaw

L jaw deviation

Speech, eating

R crown replacement and repair

Tongue depressor between teeth on the L

Jaw pain

CLZ (unknown)

N

10

F

56

2

Jaw

R jaw deviation

Speech, chewing

None

Plastic between teeth on the right and in front, holding jaw

Mild pain

THP (yes, 6 mg/d)

N

11

F

58

1

Jaw

L jaw deviation

Speech, eating

3 wks after L subdural hematoma

Plastic between teeth

None

THP (unknown)

N

12

F

50

1

Jaw

L jaw deviation

Speech

None

Holding the L jaw, imagination about holding the jaw, tongue depressor/syringe between teeth

None

THP (unknown)

N

13

M

66

7

Jaw, tongue

Jaw opening and tongue mvmts

None

None

Straw in his mouth, lightly touching lips

Difficulty chewing

CLZ (no), BoNT (no), THP (unknown)

N

14

F

56

1

Jaw, tongue

Jaw opening, tongue protrusion, alternating tongue deviation

Speech -- > eating, chewing on the R side

3 mo after traumatic facial abrasion

None

Clicking in jaw

LVT (no), TBZ (no), THP (unknown)

Y; no response

15

F

44

11

Jaw, tongue

Jaw closing, tongue retraction

Speech, chewing

Ill-fitting new denture leading to painful jaw and facial swelling

None

None

CLZ (unknown), THP (no), Baclofen (unknown), BoNT (yes, mild)

N

16

M

41

3

Jaw

Jaw protrusion

At rest, speech, eating

Skull fx and extensive L orbital bone damage, R lower molar extraction 1 y later

Tongue depressor or a pen cap between teeth

None

CLZ (yes, mild, 3–4 mg/d), THP (unknown)

Y; no response

17

M

55

2

Tongue

Tongue protrusion with 90° clockwise rotation

At rest, absent during tasks

None

None

None

LD (no), CLZ (yes, mild, 3 mg/d), BoNT (no), THP (unknown)

N

18

F

78

4

Lower face

Multiple mvmts with coexisting ET

Arrhythmic facial movements (talking > at rest); rhythmic facial movements (at rest > talking)

Dental procedure to crown several lower molar teeth

Holding chin with hand

Voice straining (started after the dental procedure), facial movements started 2 years after.

TBZ (no), CLZ (no), THP (unknown)

N

19

F

67

7

Tongue

Tongue protrusion

At rest, chewing/eating

None

None

Mild drooling and sl softening of voice, jaw tremor. Mouth ulcer

TBZ (unknown)

N

20

F

63

1

Jaw

Jaw opening, jaw protrusion

Speech (words with an "r" or "l", at rest

 

Holding a plastic syringe in the left corner of mouth

Difficulty swallowing liquids

LD (no), LZP (no), Baclofen (unknown)

N

21

M

45

1

Jaw

Jaw closing, jaw protrusion and L jaw deviation

At rest

None

Tongue depressor between teeth on the right side, touching L lower cheek

Clicking noise at the L jaw, jaw pain (L > R)

CLZ (no), Cyclobenzaprine (yes, mild), Jaw surgery (no), THP (unknown), BoNT (unknown)

Y; no response

22

M

45

2

Jaw, tongue

Jaw opening, tongue retraction

At rest, chewing

?cocaine abuse

None

None

Clonidine (yes, mild), CBZ (mild), CLZ (unknown), THP (unknown)

N

23

M

51

1

Jaw

L jaw deviation, mild jaw protrusion

At rest

None

Firm pressure on R cheek, holding object between teeth on the L side

None

LD (no), BoNT (unknown)

N

24

F

51

15

Lip, tongue, perioral muscles

Invol. dystonic mvmt of face, lips and tongue; invol. sucking mvmt of mouth

Speech, eating

None

Tongue depressor between teeth, putting hand on face

Dysphagia, 8-lb wt loss, biting cheek-- > mouth ulcers

THP (no), CLZ (no, confusion, memory problem), BoNT (yes, mild)

N

25

M

25

25

Jaw, perioral muscles

Mouth closure with sl jaw opening and protrusion

Speech, praying, chewing

None

Tongue depressor between teeth (L > R), touching jaw/chin lightly

Pain at b/l lower jaw, burning sensation in buccal mucosa, biting buccal mucosa-- > bleeding

CLZ (no, 1.5 mg/d), THP (no, 2 mg/d, dose inadequate)

N

26

M

50

 

Tongue

Tongue rolling

Speech

 

Toothpick in mouth; touch lips with finger

 

TBZ (no); THP (unknown)

Y; good response

27

M

38

 

Jaw

L jaw deviation

Speech, chewing

 

Pipette between left molars; touch left jaw

 

CLZ, THP (no)

Y; no response

28

F

60

 

Jaw

Jaw closure

Non-specific, worse with speech

 

Touch L cheek; plastic tube between teeth

 

BoNT (unknown)

N

29

F

43

 

Jaw

Jaw closure and L jaw deviation

Bassoon -- > speech, chewing

 

Device over molar; plastic appliance between teeth

 

BoNT (yes)

Prior device; good response

30

M

41

 

Jaw

Jaw closure

French horn -- > speech, drinking

 

Bite plate; straw between teeth on L

 

BoNT, CLZ, baclofen, THP (no to all)

Y; brief response

31

F

41

 

Jaw

Jaw protrusion and left jaw deviation

Speech

 

Straw between teeth, L > R

 

BoNT (unknown)

Y (bite blocks); help when bite

32

M

33

 

Lip

Lip pulling to the corners of the mouth

Speech

 

Straw between upper lip-teeth; hold upper lip with 2 fingers

 

THP (yes, 6–18 mg/d)

N

33

F

51

 

Platysma, face

Neck pull forward, grimacing

Non-specific

 

Straw between teeth on either side

 

CLZ (yes, 0.5 mg/d), BoNT (no)

N

34

M

64

 

Pharynx, larynx

Pulling

Paradoxical; worse at rest, speech better

 

Plastic between teeth

 

CLZ (unknown)

N

35

F

68

 

Jaw, tongue

Lateral movements of jaw, tongue rolling

Non-specific

 

Straw/spoon between teeth

 

THP (no); CLZ (yes, 1 mg/d)

Y; good response

36

F

66

 

Tongue

Tongue pushing against teeth (protrusion?)

Non-specific

 

Paper towel over lower front teeth; toothpick

 

Unknown

Unknown

37

M

48

 

Perioral muscles

Rotation of perioral muscles

Speech

 

Straw in his mouth

 

BoNT (yes)

Y; unknown

38

M

44

 

Tongue

Tongue rolling

Flute -- > speech

 

Plastic pipette in cheek

 

THP (yes, 4–6 mg/d)

N

41

M

30

 

Embouchure

Lowering, protrusion

Trombone

 

Touch chin or L side of face

 

None

N

42

M

66

 

Jaw, tongue

Jaw opening, tongue movements

Paradoxical; worse at rest, speech better

 

Straw between teeth

 

THP, CLZ, BoNT (no to all)

Not yet referred to M.G.

43

F

42

 

Jaw, lips

Jaw and lip opening

Speech, chewing

 

Touch R temple

 

CLZ, THP, BoNT, baclofen (no to all)

Y; brief response

Data on our new patients (number 1–25) is presented with previously published patients (number 26–43; shown in italics).

Legend: Patient number, gender, age at onset (years), duration of the disease (years), areas that are affected (arrow shows the pattern of spreading from one region to another), primary movement, task specificity, precipitating events, sensory trick, associated symptoms, treatment employed, and trial of oral devices and response are listed in columns. Patients 1 to 25 were new and patients 26 to 43 (shown in italics) were previously published [4]. Patients 39, 40 and 44 were excluded due to co-existing blepharospasm. There is no information on precipitating event in patients 26 to 43.

M, male; F, female; L, left; R, right; mvmt, movement; invol., involuntary; >, had greater effect than; fx, fracture; wk, week; mo, month; y, year; TMJ, temporomandibular joint; sl, slight; wt, weight; b/l, bilateral; LD, levodopa; BoNT, botulinum toxin injections; THP, trihexyphenidyl; CLZ, clonazepam; mg/d, milligram per day; DZP, diazepam; LVT, levetiracetam; TBZ, tetrabenazine; N, no; Y, yes. In treatment column, response is shown in the brackets (yes, no, unknown): “yes” (in patients 1 to 25), a good response; “yes, mild”, mild response, effective dose indicated in the brackets. In the oral device column, response is shown as Y and N (yes and no).

To make description of this entity more comprehensive, we have included the 16 patients with idiopathic LCrD from our previous publication in our series [4]. We excluded three patients from the previous publication who also had blepharospasm. The study was approved by the Mount Sinai Institutional Review Board. Video written-informed consent was obtained from all patients. We did not obtain separated informed consent as this is a retrospective chart review.

Results

Of 25 patients identified in the current series, 18 (68%) were female, and the mean age at evaluation was 60 years (range 44–82). Mean age at onset of symptoms was 56 (range, 25–78), 59.5 years in women and 48.6 in men. Only one patient had a positive family history, a patient with a son with an identical phenotype of rightward jaw deviation. The most common primary phenotype was a mixed dystonia (12 patients, 48%). Of the mixed phenotypes, jaw opening was the most common primary movement (4 patients). The second most common primary phenotype was jaw deviation (6 patients, 24%), followed by jaw opening (4 patients, 16%). Of 6 patients with pure jaw deviation, the jaw was deviated to the left in 4 patients and to the right in 2 patients. There was one patient each with pure jaw protrusion, pure tongue protrusion and pharyngeal/laryngeal dystonia.

In almost all patients (24/25, 96%), dystonia was task-specific. The most common task triggering dystonia was speaking (16/25, 64%), followed by eating or chewing (15/25, 60%). Thirteen patients had dystonia related to both speaking and eating/chewing. Four of these 13 demonstrated a pattern of progression of task-specificity, with dystonia initially involving speech and then progressing over time to involve eating as well. Some patients who had dystonia with chewing had difficulty specifically with hard objects. A few patients with dystonia related to speaking described a trigger with particular sounds, such as “r” or “l” sounds in one patient, and “ke” or “ge” sounds in another. Dystonia also occurred at rest in 9 patients.

Eleven patients (44%) reported a precipitating event before onset of dystonia, the most common of which was dental work within the preceding several weeks (5 patients, 20%). Two precipitating events related to injury or manipulation of maxillofacial bones included a traumatic mandibular fracture after a fall and maxillary bridge replacement. The latter patient was required to hold her mouth open for 2 hours while the temporary bridge was fit. Other precipitating events included a history of a left subdural hematoma 3 weeks prior, and a skull fracture with extensive left orbital bone damage from a car accident.

Geste antagonistes were found in 18 patients (72%). The most common one observed on examination was holding an object such as a piece of plastic, a tongue depressor, syringe or straw between the teeth, in 17 out of 18 patients. Six patients demonstrated marked side specificity of the geste: improvement when placing the trick device between teeth on one side but not the other side. Complete data on side specificity in all patients could not be assessed due to lack of testing. There was no clear relationship between the phenomenology of dystonia (for example, the side that the jaw deviated to) and the side specificity of this geste antagoniste. Ten patients also had improvement in dystonia when lightly touching the jaw, chin or face with finger(s) or a hand. One of these ten patients had improvement even when he imagined holding his jaw. Three reported improvement with chewing gum, one of which had side specificity on the left.

Stress and fatigue were aggravating factors in some patients. The most common associated symptom was jaw pain (5 patients, 20%). A clicking noise in the jaw or ear was found in 4 patients (16%). Dysphagia was found in 2 patients: one had severe weight loss and the other had dysphagia only with liquids. Two patients reported mouth ulcers or bleeding from biting buccal mucosa.

Oral medication and botulinum toxin injections were employed in treatment. Oral medications included trihexyphenidyl (21 patients, 84%), clonazepam (15 patients, 60%), baclofen (5 patients, 20%) and levodopa (4 patients, 16%). Propranolol, carbamazepine and clonidine were each also used in one patient. The most common daily dose of trihexyphenidyl was 6 mg/day in 10 patients (range 1–19 mg). Of 21 patients treated with trihexyphenidyl, three had response with very good benefit at the dose of 2–15 mg/day, seven did not have benefit and the response was unknown in 11 patients. Of 15 patients treated with clonazepam, two had response that was only mild at the dose of 1.5-3 mg/day, nine had no response and the response was unknown in four patients. Baclofen was employed in 5 patients, none of whom had a good response, three had no response and the response was unknown in the other two patients. Of data available, the dose of baclofen employed was 10–30 mg/day.

Ten patients (40%) underwent botulinum toxin (BoNT) injections. The sites of the injections depended on the primary movement, mostly external or internal pterygoids. There was a response that was only mild in three patients, one of whom continued to have significant disability. Five patients had no response to BoNT injections and the response was unknown in two patients.

With regards to side effects, confusion, mild tendency to sadness and anxiety each were found in one patient each taking trihexyphenidyl at 3–6 mg/day. Side effects from clonazepam included anxiety, confusion/memory problem, and sedation, each found in one patient taking the dose of 1–1.5 mg/day. One patient who received BoNT injections was complicated by marked dysphagia. Depression and rash each were found in one patient taking tetrabenazine.

Table 2 illustrates the comparison of results combining our 25 new patients with 16 patients from the previously published series, when analyzing the new patients compared to all 41 patients. The results with regards to sex predilection, areas affected, primary movement, task-specificity, geste antagoniste, treatment employed and response to the treatment were similar. Of note, 3 patients from the previously published series had task specificity related to performance on a brass or woodwind musical instrument (embouchure dystonia).
Table 2

Comparison of results between new patients and combined data with the previous publication

 

New patients

Combined data

Number of the patients

25

41

Sex

Female 18/25 (72%)

Female 24/41 (58.5%)

 

Male 7/25 (28%)

Male 17/41 (41.5%)

Female/male (F/M ratio)

2.6:1

1.4:1

Average age at onset (years)

56

53.3

 In female subgroup

59.5

48.6

 In male subgroup

48.6

47.2

Areas affected

  

 Jaw only (including mixed primary movements of jaw)

15 (60%)

20 (48.8%)

 Lip or perioral only

0 (0%)

2 (4.9%)

 Tongue only

2 (8%)

5 (12.2%)

 Pharynx/larynx

1 (4%)

2 (4.9%)

 Mixed

7 (28%)

11 (26.8%)

  Jaw and tongue

4 (16%)

6 (14.6%)

Primary movement

  

 Pure jaw deviation

6 (24%)

7 (17%)

  to the left

4 (16%)

5 (12.2%)

 Pure jaw opening

4 (16%)

4 (9.8%)

 Mixed

12 (48%)

17 (41.5%)

Task specificity

  

 Speech

18 (72%)

27 (65.9%)

 Eating/chewing

15 (60%)

18 (43.9%)

 At rest

9 (36%)

11 (26.8%)

 Musical instrument

0 (0%)

4 (9.8%)

Geste antagoniste

18 (72%)

34 (82.9%)

 Object between teeth

17 (68%)

31 (75.6%)

  with side specificity

6 (24%)

8 (19.5%)

 Holding body part lightly

10 (40%)

15 (36.6%)

  with side specificity

4 (16%)

8 (19.5%)

Treatment

  

THP

21 (84%)

29 (70.7%)

  good response

3 (12%)

5 (12.2%)

CLZ

15 (60%)

22 (53.7%)

  good response

2 (8%) - all mild

4 (9.8%)

Baclofen

5 (20%)

7 (17%)

  good response

0 (0%)

0 (0%)

BoNT

10 (40%)

18 (43.9%)

  good response

3 (12%) - all mild

5 (12.2%)

Dental device

4 (16%)

11 (26.8%)

  good response

0 (0%)

2 (4.9%)

Legend: Data on our 25 patients and combined 41 is shown in the middle and right columns, respectively. Number of patients, sex, average age at onset, areas affected, primary movement, task specificity, geste antagoniste, and treatment employed are listed in the left column. With regards to areas affected, note that “jaw only” group also includes patients with mixed primary movement of the jaw such as mixed jaw opening and protrusion. With regards to geste antagoniste, data on side specificity, either left or right, is shown. Numbers of the patients on each treatment modality and the ones with a good response are shown. Data on “no-response” and “unknown” group is not shown here. All numerical data (except average age at onset) represent numbers of the patient with percentage (in the brackets) of total number of the patients in each group, 25 and 41, respectively, are shown.

THP, trihexyphenidyl; CLZ, clonazepam; BoNT, botulinum toxin injections.

The following case histories illustrate the clinical entity (see video in Additional file 1).

Patient 2: pure jaw deviation

A 72-year-old woman suffered a traumatic mandible fracture after a fall. Her jaw was wired shut for six weeks. On recovering from surgery, she immediately became aware of a change in the way her jaw felt. She noticed that her right molars were no longer contacting one another when she chewed; eating, chewing and speaking were difficult, and her jaw would move spontaneously to the left. She had no history of neuroleptic or anti-emetic exposure. She was not aware of any sensory tricks. Examination revealed mild jaw dystonia with leftward shift, mildly accentuated by speaking. There was no clear change with holding a plastic syringe between her teeth on either side. She was started on trihexyphenidyl 2 mg daily with titration to 2 mg twice a day. She had a very good sustained response even when decreasing the dose down to 2 mg/day.

Patient 17: pure lingual dystonia

A 57-year-old man developed involuntary movements of the tongue over a period of two years. He did not identify any sensory tricks, and there was no history of precipitating factors, neuroleptic or antiemetic exposure. Examination revealed mild protrusion and rotation of the tongue in a 90-degree clockwise fashion. Movements were not triggered by tasks, and indeed were absent when he spoke. We were not able to identify any sensory tricks such as placing a tongue depressor or a small plastic bite block between his teeth. He had been treated with botulinum toxin injections, without apparent benefit, and with clonazepam, with mild benefit at the dose of 3 mg/day. He was then started on trihexyphenidyl with a slow titration schedule up to 6 mg/day (in 3 divided doses) without either benefits or side effects. We increased the dose to 12 mg/day (in 3 divided doses). The response with this dose was unknown as further follow-up information was not available.

Patient 3: mixed dystonia

A 61-year-old woman underwent a maxillary bridge replacement four years prior to being seen. A temporary bridge was made and her mouth was open for two hours while this was fit. Since that time, she felt that her jaw alignment was incorrect, and she developed difficulty with her speech, jaw pain and clicking in her temporomandibular joints (TMJs). In the last year she noticed movements involving the tongue and jaw, initially limited to the task of speaking. Over time, movements spread to involve eating and chewing, sparing drinking. There was no history of neuroleptic or anti-emetic exposure. She saw a dentist and tried multiple oral devices without benefit. Examination revealed a tendency of the jaw to open and push forward anteriorly at rest. When she spoke, movements were further activated causing mild dysarthria. Holding a piece of plastic between her teeth immediately improved her speaking. She was started on low dose trihexyphenidyl with slow titration to 2 mg three times daily without benefit. We then referred her for botulinum toxin injections.

Discussion

In this series, the largest of such patients reported, idiopathic LCrD was more common in women than men (2:1). This is similar to the pre-existing literature on LCrD and other forms of focal dystonia such as cervical dystonia (female/male; F/M ratio 1.2-1.92:1) [917], blepharospasm (F/M ratio 1.35-2:1) [9, 1820], spasmodic dysphonia (F/M ratio 1.35-15:1) [9, 2124], and oromandibular dystonia 3.28:1 [9], but opposite to what is seen in writer’s cramp (F/M ratio of 1:2) [9]. Almost half of our patients had a mixed phenotype and the other half were simpler (pure). In the group with pure phenotype, the most common primary movement was jaw deviation, whereas jaw opening was the most common phenotype of mixed phenotype. Jaw protrusion, as well as tongue and pharyngeal dystonia was much less common.

The anatomy and function of the jaw is unique. Embryologically the jaw muscles are derived from presomitic mesoderm of the first branchial arch [25], whereas limb muscles are derived from somites. The multiple functions of the jaw are complex as well. Chewing requires complex coordinated movements of various jaw muscles. Masticatory myosin is expressed in the jaw, and during evolution it is replaced with other types of myosin to tailor for eating habits or types of diet [26]. In humans jaw closing muscles contain rich muscle spindle innervation whereas jaw-opening muscles do not [27, 28], possibly due to the strong proprioceptive input related to jaw closure for modifying bite strength. One possible reason for this is the evolutionary pressure that modifies the bite. For example, humans can modulate bite strength to match different consistencies of food, and many mammals and vertebrates must be able to exert tremendous force with the jaw to capture prey, but also modify their bite so as to gently carry their young. These unique features of the jaw muscles might explain the common and often robust sensory gestes observed in our patients.

Task specificity is a nearly universal feature of LCrD, and the most common triggering tasks were speaking, followed by eating or chewing. Often dystonia began with speaking, and then spread to eating or chewing. We did not observe other patterns of spread of dystonic tasks. Recent dental work or oral trauma may precipitate LCrD, as can manipulation of the facial bones, especially the maxilla and mandible. There may be a role of “osseoperception” [29, 30]; afferent signal from periodontal mechanoreceptor is required in fine motor control of the mandible such as chewing or jaw closing. However, this concept can explain only some, but not all, patients such as in the ones who had tooth extraction as a precipitating event. In addition, it does not explain non-jaw related dystonia such as lingual dystonia after dental work.

3/4 of our patients possessed a geste antagoniste, and all of those had improvement of LCrD by holding an object between their teeth. Some improved when lightly holding the chin and jaw, and occasionally with imagination of the sensory trick. This feature is a key diagnostic aide, and the presence or absence of a sensory trick should be investigated in all such patients. The numbers are too small to support a clear relationship between the presence of a geste antagoniste and treatment response in our series. Of 9 patients with response to at least one treatment modality, six had at least one sensory trick, whereas 12 of 16 patients without treatment response did not have an identified sensory trick.

The most common treatment used in our patients was trihexyphenidyl, the response of which was more robust than the other modalities, but still disappointing. None of the patients had good response to baclofen or dental device in our series. Response to botulinum toxin injection was less robust than in other series, for reasons that are not clear.

Conclusion

Idiopathic LCrD is often missed and institution of effective therapy is often delayed. The clinical features and natural history of LCrD are similar to other forms of focal dystonia.

We offer the following practical guidelines for clinicians who evaluate patients with LCrD. Table 3 illustrates clinical approach to patients with LCrD. The differential diagnoses of idiopathic LCrD includes other primary dystonia (such as primary segmental dystonia, Meige’s syndrome), secondary dystonia (such as tardive dystonia from dopamine receptor blocking agents, infectious dystonia including anti-NMDA encephalitis), heredodegenerative dystonia (such as X-linked dystonia parkinsonism or Lubag’s disease, neuroacanthocytosis, Lesch-Nyhan syndrome, SCA 8 [31], cerebrotendinous xanthomatosis) [32], and pseudodystonia. Pseudodystonia in the differential diagnoses of LCrD include Isaac’s syndrome, tetanus, and musculoskeletal abnormalities such as Satoyoshi syndrome.
Table 3

Practical guideline in evaluation of patients with LCrD

History

Onset

Description of the abnormal movement or sensation

Precipitating factor (especially history of recent dental work or maxillofacial trauma) lower cranial

Aggravating and relieving factors

Associated symptoms such as pain, jaw clicking

Sensory tricks

History of previous treatment such as dental prosthesis

History of secondary causes of dystonia especially dopamine receptor blocking agent exposure

Examination

Identify the primary movement(s)

 

o Jaw in each axis: opening/closing, lateral deviation (left/right), protrusion/retraction

 

o Tongue: protrusion/retraction, torsion

Determine task specificity (dystonia occurs with speaking, eating/chewing and/or at rest)

Identify sensory tricks: light touch, placing objects such as plastic syringe or tongue depressor between teeth on each side and in the center

Assess evidence of dystonia in other body parts especially in upper cranial region, voice and neck

Legend: Practical guideline in history taking and physical examination of patients with LCrD is described.

We hope that this paper will call attention to this entity, and aide dental professionals, general physicians and neurologists in securing the correct diagnosis.

Abbreviations

BoNT: 

Botulinum toxin

F/M: 

Female/male

LCrD: 

Lower cranial dystonia

NBIA: 

Neurodegeneration with brain iron accumulation

NMDA: 

N-methyl-D-aspartate

SCA: 

Spinocerebellar ataxia

TMJ: 

Temporomandibular joint.

Declarations

Authors’ Affiliations

(1)
Department of Neurology, Movement Disorders Division, Icahn School of Medicine at Mount Sinai

References

  1. Robertson-Hoffman DE, Mark MH, Sage JI: Isolated lingual/palatal dystonia. Mov Disord 1991, 6: 177–179. 10.1002/mds.870060217View ArticlePubMedGoogle Scholar
  2. Tan EK, Jankovic J: Tardive and idiopathic oromandibular dystonia: a clinical comparison. J Neurol Neurosurg Psychiatry 2000, 68: 186–190. 10.1136/jnnp.68.2.186View ArticlePubMedPubMed CentralGoogle Scholar
  3. Singer C, Papapetropoulos S: A comparison of jaw-closing and jaw-opening idiopathic oromandibular dystonia. Parkinsonism Relat Disord 2006, 12: 115–118. 10.1016/j.parkreldis.2005.07.007View ArticlePubMedGoogle Scholar
  4. Lo SE, Gelb M, Frucht SJ: Geste antagonistes in idiopathic lower cranial dystonia. Mov Disord 2007, 22: 1012–1017. 10.1002/mds.21149View ArticlePubMedGoogle Scholar
  5. Esper CD, Freeman A, Factor SA: Lingual protrusion dystonia: frequency, etiology and botulinum toxin therapy. Parkinsonism Relat Disord 2010, 16: 438–441. 10.1016/j.parkreldis.2010.04.007View ArticlePubMedGoogle Scholar
  6. Charous SJ, Comella CL, Fan W: Jaw-opening dystonia: quality of life after botulinum toxin injections. Ear Nose Throat J 2011, 90: E9.PubMedGoogle Scholar
  7. Costa AL, Campos LS, Franca MC Jr, D'Abreu A: Temporomandibular disorders in patients with craniocervical dystonia. Arq Neuropsiquiatr 2011, 69: 896–899. 10.1590/S0004-282X2011000700009View ArticlePubMedGoogle Scholar
  8. Bakke M, Larsen BM, Dalager T, Moller E: Oromandibular dystonia–functional and clinical characteristics: a report on 21 cases. Oral Surg Oral Med Oral Pathol Oral Radiol 2013, 115: e21-e26.View ArticlePubMedGoogle Scholar
  9. Soland VL, Bhatia KP, Marsden CD: Sex prevalence of focal dystonias. J Neurol Neurosurg Psychiatry 1996, 60: 204–205. 10.1136/jnnp.60.2.204View ArticlePubMedPubMed CentralGoogle Scholar
  10. Friedman A, Fahn S: Spontaneous remissions in spasmodic torticollis. Neurology 1986, 36: 398–400. 10.1212/WNL.36.3.398View ArticlePubMedGoogle Scholar
  11. Duane DD: Spasmodic torticollis: clinical and biologic features and their implications for focal dystonia. Adv Neurol 1988, 50: 473–492.PubMedGoogle Scholar
  12. Jahanshahi M, Marion MH, Marsden CD: Natural history of adult-onset idiopathic torticollis. Arch Neurol 1990, 47: 548–552. 10.1001/archneur.1990.00530050070014View ArticlePubMedGoogle Scholar
  13. Jankovic J, Schwartz K: Botulinum toxin injections for cervical dystonia. Neurology 1990, 40: 277–280. 10.1212/WNL.40.2.277View ArticlePubMedGoogle Scholar
  14. Chan J, Brin MF, Fahn S: Idiopathic cervical dystonia: clinical characteristics. Mov Disord 1991, 6: 119–126. 10.1002/mds.870060206View ArticlePubMedGoogle Scholar
  15. Jankovic J, Leder S, Warner D, Schwartz K: Cervical dystonia: clinical findings and associated movement disorders. Neurology 1991, 41: 1088–1091. 10.1212/WNL.41.7.1088View ArticlePubMedGoogle Scholar
  16. Deuschl G, Heinen F, Kleedorfer B, Wagner M, Lucking CH, Poewe W: Clinical and polymyographic investigation of spasmodic torticollis. J Neurol 1992, 239: 9–15. 10.1007/BF00839204View ArticlePubMedGoogle Scholar
  17. Jamora RD, Tan AK, Tan LC: A 9-year review of dystonia from a movement disorders clinic in Singapore. Eur J Neurol 2006, 13: 77–81. 10.1111/j.1468-1331.2006.01150.xView ArticlePubMedGoogle Scholar
  18. Cohen DA, Savino PJ, Stern MB, Hurtig HI: Botulinum injection therapy for blepharospasm: a review and report of 75 patients. Clin Neuropharmacol 1986, 9: 415–429. 10.1097/00002826-198610000-00002View ArticlePubMedGoogle Scholar
  19. Carruthers J, Stubbs HA: Botulinum toxin for benign essential blepharospasm, hemifacial spasm and age-related lower eyelid entropion. Can J Neurol Sci 1987, 14: 42–45.PubMedGoogle Scholar
  20. Grandas F, Elston J, Quinn N, Marsden CD: Blepharospasm: a review of 264 patients. J Neurol Neurosurg Psychiatry 1988, 51: 767–772. 10.1136/jnnp.51.6.767View ArticlePubMedPubMed CentralGoogle Scholar
  21. Jankovic J, Ford J: Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients. Ann Neurol 1983, 13: 402–411. 10.1002/ana.410130406View ArticlePubMedGoogle Scholar
  22. Ludlow CL, Naunton RF, Sedory SE, Schulz GM, Hallett M: Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia. Neurology 1988, 38: 1220–1225. 10.1212/WNL.38.8.1220View ArticlePubMedGoogle Scholar
  23. Rosenfield DB: Spasmodic dysphonia. Adv Neurol 1988, 50: 537–545.PubMedGoogle Scholar
  24. Blitzer A, Brin MF, Fahn S, Lovelace RE: Clinical and laboratory characteristics of focal laryngeal dystonia: study of 110 cases. Laryngoscope 1988, 98: 636–640.View ArticlePubMedGoogle Scholar
  25. Noden DM: The embryonic origins of avian cephalic and cervical muscles and associated connective tissues. Am J Anat 1983, 168: 257–276. 10.1002/aja.1001680302View ArticlePubMedGoogle Scholar
  26. Hoh JF: 'Superfast' or masticatory myosin and the evolution of jaw-closing muscles of vertebrates. J Exp Biol 2002, 205: 2203–2210.PubMedGoogle Scholar
  27. Lennartsson B: Muscle spindles in the human anterior digastric muscle. Acta Odontol Scand 1979, 37: 329–333. 10.3109/00016357909004704View ArticlePubMedGoogle Scholar
  28. Kubota K, Masegi T: Muscle spindle supply to the human jaw muscle. J Dent Res 1977, 56: 901–909. 10.1177/00220345770560081201View ArticlePubMedGoogle Scholar
  29. Trulsson M: Sensory and motor function of teeth and dental implants: a basis for osseoperception. Clin Exp Pharmacol Physiol 2005, 32: 119–122. 10.1111/j.1440-1681.2005.04139.xView ArticlePubMedGoogle Scholar
  30. Klineberg I, Murray G: Osseoperception: sensory function and proprioception. Adv Dent Res 1999, 13: 120–129. 10.1177/08959374990130010101View ArticlePubMedGoogle Scholar
  31. Ushe M, Perlmutter JS: Oromandibular and lingual dystonia associated with spinocerebellar ataxia type 8. Mov Disord 2012, 27: 1741–1742. 10.1002/mds.25295View ArticlePubMedPubMed CentralGoogle Scholar
  32. Alcalay R, Wu S, Patel S, Frucht S: Oromandibular dystonia as a complication of cerebrotendinous xanthomatosis. Mov Disord 2009, 24: 1397–1399. 10.1002/mds.22585View ArticlePubMedGoogle Scholar

Copyright

© Termsarasab et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement